Zivo Bioscience, Inc.·4

Apr 8, 3:24 PM ET

RICE II PHILIP M 4

4 · Zivo Bioscience, Inc. · Filed Apr 8, 2020

Insider Transaction Report

Form 4
Period: 2018-02-21
RICE II PHILIP M
Chief Financial Officer
Transactions
  • Award

    Common Stock Purchase Warrant

    2019-10-28+50,00050,000 total
    Exercise: $0.08From: 2019-10-28Exp: 2024-10-28Common Stock (50,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2018-09-28+500,000500,000 total
    Exercise: $0.14From: 2018-09-28Exp: 2023-09-28Common Stock (500,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2019-05-13+50,00050,000 total
    Exercise: $0.10From: 2019-05-13Exp: 2024-05-13Common Stock (50,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2018-02-21+50,00050,000 total
    Exercise: $0.11From: 2018-02-21Exp: 2023-02-21Common Stock (50,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2018-08-14+50,00050,000 total
    Exercise: $0.12From: 2018-08-14Exp: 2023-08-14Common Stock (50,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2018-11-14+50,00050,000 total
    Exercise: $0.14From: 2018-11-14Exp: 2023-11-14Common Stock (50,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2019-08-07+50,00050,000 total
    Exercise: $0.10From: 2019-08-07Exp: 2024-08-07Common Stock (50,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2019-02-13+50,00050,000 total
    Exercise: $0.10From: 2019-02-13Exp: 2024-02-13Common Stock (50,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2019-09-26+500,000500,000 total
    Exercise: $0.08From: 2019-09-26Exp: 2024-09-26Common Stock (500,000 underlying)
  • Award

    Common Stock Purchase Option

    2020-03-04+2,000,0002,000,000 total
    Exercise: $0.15From: 2020-03-04Exp: 2030-03-04Common Stock (2,000,000 underlying)
  • Award

    Common Stock Purchase Warrant

    2018-04-23+50,00050,000 total
    Exercise: $0.10From: 2018-04-23Exp: 2023-04-23Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer.
  • [F2]The warrants were issued to the reporting person as compensation for acting as a director.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT